BUD31 and ovarian carcinoma: In contrast, knockdown of BUD31 in HEYA8, OV90, OVBWZX (primary ovarian cancer cells derived from the ascites of SOC patients, verified by PAX8 and p53) reduced the number of EdU-positive cells (Figs. 3a and S3a, b).